B

BioRestorative Therapies
D

BRTX

1.51000
USD
-0.02
(-1.31%)
Market Closed
Volume
538
EPS
0
Div Yield
0
P/E
-2
Market Cap
10,449,078
OverviewSignalsIdeasNews
Related Instruments
    A
    AYRO
    -0.01200
    (-1.65%)
    0.71500 USD
    B
    BLNK
    -0.24500
    (-7.42%)
    3.05500 USD
    F
    -0.120
    (-1.11%)
    10.700 USD
    GM
    -0.960
    (-2.17%)
    43.360 USD
    N
    NIO
    -0.38000
    (-8.54%)
    4.07000 USD
    N
    NKLA
    -0.43500
    (-4.84%)
    8.54500 USD
    P
    PLUG
    -0.16000
    (-6.48%)
    2.31000 USD
    R
    RIVN
    -1.170
    (-7.13%)
    15.250 USD
    TSLA
    -15.15
    (-6.53%)
    311.18 USD
    W
    WKHS
    -0.11000
    (-7.59%)
    1.34000 USD
    More
News

Title: BioRestorative Therapies

Sector: Healthcare
Industry: Biotechnology
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.